Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Sotio Biotech Inc.
AIDS Malignancy Consortium
Hoffmann-La Roche
Seagen Inc.
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Kansas Medical Center
Radiation Therapy Oncology Group
Seagen Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Southern California
University of California, San Diego
New Mexico Cancer Research Alliance
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
Regeneron Pharmaceuticals
National Institutes of Health Clinical Center (CC)
Baylor College of Medicine
Thomas Jefferson University
UNC Lineberger Comprehensive Cancer Center
Incyte Corporation
UNC Lineberger Comprehensive Cancer Center
Sichuan Enray Pharmaceutical Sciences Company
Merck Sharp & Dohme LLC
Agenus Inc.
Genexine, Inc.
University of Minnesota
University of Virginia
Duke University
GOG Foundation
Baptist Health South Florida
BeiGene
Stanford University
National Institutes of Health Clinical Center (CC)
Brown University
Kymab Limited
University of Virginia
UNC Lineberger Comprehensive Cancer Center
PATH
University of Rochester
Canadian Cancer Trials Group
Imperial College London
University of California, San Diego
University of Kentucky
University of Virginia
Massachusetts General Hospital